Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Signs on Eisai as a Customer for Chemogenomics Profiling Services

NEW YORK, April 14 - Iconix pharmaceuticals has signed on Japanese pharma Eisai Co. as a service customer for its chemogenomic profiling and analytical services, the company said today.


Under the agreement, Iconix and Eisai will use Iconix' DrugMatrix chemogenomics system to evaluate Eisai's early-stage drug candidates. Specifically, Eisai hopes to gain an understanding of the toxicology, off-target effects, and mechanism of action in compounds.


Iconix, of Mountain View, Calif., has developed its DrugMatrix system along with MDS Pharma and Incyte, and has integrated its tools with Spotfire's visualization capabilities.


The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.